Eficacia de la terapia antiangiogénica sobre las membranas neovasculares retinales
The objective of this research is to establish the effectiveness of antiangiogenic drugs for the treatment of the neovascular membrane produced in high myopia, and exudative AMD; used at the Neiva Oftalmolaser Clinic between 2013 and 2020. The research is retrospective. For data collection, a review...
- Autores:
-
Gaviria Polania, Juanita
Murcia Tovar, Laura Sofia
Cardoso Lozano, Wiston
- Tipo de recurso:
- Trabajo de grado de pregrado
- Fecha de publicación:
- 2021
- Institución:
- Universidad Antonio Nariño
- Repositorio:
- Repositorio UAN
- Idioma:
- spa
- OAI Identifier:
- oai:repositorio.uan.edu.co:123456789/6282
- Acceso en línea:
- http://repositorio.uan.edu.co/handle/123456789/6282
- Palabra clave:
- Membrana neovascular
Degeneración macular asociada a la edad
Miopía patológica
Terapia anti angiogénica
Tratamiento de retina
613
Neovascular membrane
Age-related macular degeneration
Anti-angiogenic therapy
Retina treatment
- Rights
- openAccess
- License
- Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
| Summary: | The objective of this research is to establish the effectiveness of antiangiogenic drugs for the treatment of the neovascular membrane produced in high myopia, and exudative AMD; used at the Neiva Oftalmolaser Clinic between 2013 and 2020. The research is retrospective. For data collection, a review of information was carried out, of ophthalmological medical records from the years 2013 to 2020 of the Oftalmolaser Clinic of the city of Neiva and results were found regarding the recovery or stabilization of visual acuity and the combination of antiangiogenic drugs during treatment; concluding that the most used drug is Ranibizumab and that the total number of eyes that improved was 45.2%. |
|---|